ELV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Elevance Health, Inc. (ELV)
Company Research
Source: GlobeNewswire
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it “was notified by the Centers for Medicare & Medicaid Services (‘CMS’) of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company’s Medicare Advantage-Prescription Drug (‘MA-PD’) plans and suspending certain communication activities to Medicare beneficiaries.” Elevance said that “CMS has indicated that the proposed sanctions relate to alleged noncompliance by the Company with certain Medicare Advantage risk adjustment dat
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (ELV) had its price target lowered by Robert W. Baird from $340.00 to $317.00. They now have a "neutral" rating on the stock.MarketBeat
- Elevance Health (ELV) had its price target lowered by Truist Financial Corporation from $390.00 to $375.00. They now have a "buy" rating on the stock.MarketBeat
- Elevance Health (ELV) is now covered by Evercore Inc. They set an "in-line" rating and a $345.00 price target on the stock.MarketBeat
- BofA Updates Managed Care Outlook, Raises Elevance Health (ELV) Price Target [Yahoo! Finance]Yahoo! Finance
- Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS rally [Yahoo! Finance]Yahoo! Finance
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 4/7/26 - Form PX14A6G
- 3/27/26 - Form DEF
- 3/27/26 - Form DEFA14A
- ELV's page on the SEC website